Avalo Therapeutics, Inc. · NASDAQ:AVTX

Deep Track Capital, LP reported a 5.81% stake in Avalo Therapeutics, Inc. (Schedule 13G)

Event May 22, 2026 · Filed May 29, 2026

Deep Track Capital, LP reported a 5.81% stake in Avalo Therapeutics, Inc., 3,055,027 shares, as a passive investor on May 22, 2026. Filed May 29, 2026 (Schedule 13G).

Stake
5.81%
Shares
3,055,027
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.81%3,055,027
Deep Track Biotechnology Master Fund, Ltd.5.81%3,055,027
David Kroin5.81%3,055,027

Source

View original at SEC

Related